Pain, Post-operative Clinical Trial
Official title:
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Evaluation of the Safety of N1539 Following Major Surgery
The primary objective of this study is to evaluate the safety and tolerability of N1539 in a variety of post-surgical conditions.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02284243 -
Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery
|
Phase 2 | |
Completed |
NCT03456141 -
Multimodal Analgesic Protocol to Moderate Acute Pain
|
||
Terminated |
NCT02169336 -
Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy
|
Phase 2 | |
Not yet recruiting |
NCT05950152 -
Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery
|
Phase 2 | |
Completed |
NCT02675907 -
Evaluation of N1539 Following Bunionectomy Surgery
|
Phase 3 | |
Completed |
NCT02678286 -
Evaluation of N1539 Following Abdominoplasty Surgery
|
Phase 3 | |
Unknown status |
NCT01041313 -
Memantine for Post-Operative Pain Control
|
Phase 4 | |
Completed |
NCT02540265 -
Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery
|
Phase 2 | |
Completed |
NCT03154658 -
Serratus Anterior Plane Block in Patients Undergoing Mastectomy
|
Phase 4 |